Promoter analysis of the DHCR24 (3β-hydroxysterol Δ 24-reductase) gene: Characterization of SREBP (sterol- regulatoryelement-binding protein)-mediated activation

Bioscience Reports

Volumn 33, Issue 1, 2013, Pages 57-69

  Daimiel, Lidia A ^a,b   Fernández Suarez, María E ^a,b   Rodríguez Acebes, Sara ^a,b   Crespo, Lorena ^a   Lasunción, Miguel A ^a,b,c   Gómez Coronado, Diego ^a,b   Martínez Botas, Javier ^a,b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

3 hydroxysterol 24 reductase (DHCR24); Androgen; Cholesterol; Kr ppel like factor 5 (KLF5); Promoter analysis; Sterol regulatory element binding protein (SREBP)

Indexed keywords

3BETA HYDROXYSTEROL DELTA24 REDUCTASE; ANDROSTANOLONE; CHOLESTEROL; CIS ACTING ELEMENT; KRUPPEL LIKE FACTOR 5; MESSENGER RNA; MEVINOLIN; OXIDOREDUCTASE; STEROL REGULATORY ELEMENT; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

3BETA HYDROXYSTEROL DELTA24 REDUCTASE GENE; ARTICLE; CHOLESTEROL METABOLISM; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; GEL MOBILITY SHIFT ASSAY; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION SITE;

BASE SEQUENCE; CHROMATIN IMMUNOPRECIPITATION; CLONING, MOLECULAR; DIHYDROTESTOSTERONE; DRUG SYNERGISM; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENES, REPORTER; HEP G2 CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIPOPROTEINS, LDL; LOVASTATIN; LUCIFERASES; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION INITIATION SITE; TRANSCRIPTIONAL ACTIVATION;

EID: 84872735485     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20120095     Document Type: Article

References (50)

1. Brown, M. S. and Goldstein, J. L. (2009) Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J. Lipid Res. 50, S15-S27
2. Shimano, H. (2001) Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog. Lipid Res. 40, 439-452
3. Horton, J. D., Goldstein, J. L. and Brown, M. S. (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131
4. Ericsson, J., Usheva, A. and Edwards, P. A. (1999) YY1 is a negative regulator of transcription of three sterol regulatory element-binding protein-responsive genes. J. Biol. Chem. 274, 14508-14513
5. Bae, S. H. and Paik, Y. K. (1997) Cholesterol biosynthesis from lanosterol: development of a novel assay method and characterization of rat liver microsomal lanosterol -24-reductase. Biochem. J. 326, 609-616
6. FitzPatrick, D. R., Keeling, J. W., Evans, M. J., Kan, A. E., Bell, J. E., Porteous, M. E., Mills, K., Winter, R. M. and Clayton, P. T. (1998) Clinical phenotype of desmosterolosis. Am. J. Med. Genet. 75, 145-152
7. Greeve, I., Hermans-Borgmeyer, I., Brellinger, C., Kasper, D., Gomez-Isla, T., Behl, C., Levkau, B. and Nitsch, R. M. (2000) The human DIMINUTO/DWARF1 homolog seladin-1 coresistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J. Neurosci. 20, 7345-7352
8. Wu, C., Miloslavskaya, I., Demontis, S., Maestro, R. and Galaktionov, K. (2004) Regulation of cellular response to oncogenic and oxidative stress by Seladin-1. Nature 432, 640-645
9. Lu, X., Kambe, F., Cao, X., Kozaki, Y., Kaji, T., Ishii, T. and Seo, H. (2008) 3?-Hydroxysteroid-24 reductase is a hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis. Endocrinology 149, 3267-3273
10. Sarkar, D., Imai, T., Kambe, F., Shibata, A., Ohmori, S., Siddiq, A., Hayasaka, S., Funahashi, H. and Seo, H. (2001) The human homolog of Diminuto/Dwarf1 gene (hDiminuto): a novel ACTH-responsive gene overexpressed in benign cortisol-producing adrenocortical adenomas. J. Clin. Endocrinol. Metab. 86, 5130-5137
11. Luciani, P., Gelmini, S., Ferrante, E., Lania, A., Benvenuti, S., Baglioni, S., Mantovani, G., Cellai, I., Ammannati, F., Spada, A. et al. (2005) Expression of the antiapoptotic gene seladin-1 and octreotide-induced apoptosis in growth hormone-secreting and nonfunctioning pituitary adenomas. J. Clin. Endocrinol. Metab. 90, 6156-6161
12. Fuller, P. J., Alexiadis, M., Jobling, T. and McNeilage, J. (2005) Seladin-1/DHCR24 expression in normal ovary, ovarian epithelial and granulosa tumours. Clin. Endocrinol. 63, 111-115
13. Di Stasi, D., Vallacchi, V., Campi, V., Ranzani, T., Daniotti, M., Chiodini, E., Fiorentini, S., Greeve, I., Prinetti, A., Rivoltini, L. et al. (2005) DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis. Int. J. Cancer 115, 224-230
14. Bonaccorsi, L., Luciani, P., Nesi, G., Mannucci, E., Deledda, C., Dichiara, F., Paglierani, M., Rosati, F., Masieri, L., Serni, S. et al. (2008) Androgen receptor regulation of the seladin-1/DHCR24 gene: altered expression in prostate cancer. Lab. Invest. 88, 1049-1056
15. Simi, L., Malentacchi, F., Luciani, P., Gelmini, S., Deledda, C., Arvia, R., Mannelli, M., Peri, A. and Orlando, C. (2010) Seladin-1 expression is regulated by promoter methylation in adrenal cancer. BMC Cancer 10, 201
16. Crameri, A., Biondi, E., Kuehnle, K., Lutjohann, D., Thelen, K. M., Perga, S., Dotti, C. G., Nitsch, R. M., Ledesma, M. D. and Mohajeri, M. H. (2006) The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and A beta generation in vivo. EMBO J. 25, 432-443
17. Takano, T., Tsukiyama-Kohara, K., Hayashi, M., Hirata, Y., Satoh, M., Tokunaga, Y., Tateno, C., Hayashi, Y., Hishima, T., Funata, N. et al. (2011) Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes. J. Hepatol. 55, 512-521
18. McGrath, K. C., Li, X. H., Puranik, R., Liong, E. C., Tan, J. T., Dy, V. M., DiBartolo, B. A., Barter, P. J., Rye, K. A. and Heather, A. K. (2009) Role of 3beta-hydroxysteroid-24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 29, 877-882
19. Patel, S., Di Bartolo, B. A., Nakhla, S., Heather, A. K., Mitchell, T. W., Jessup, W., Celermajer, D. S., Barter, P. J. and Rye, K. A. (2010) Anti-inflammatory effects of apolipoprotein A-I in the rabbit. Atherosclerosis 212, 392-397
20. Fernandez, C., Suarez, Y., Ferruelo, A. J., Gomez-Coronado, D. and Lasuncion, M. A. (2002) Inhibition of cholesterol biosynthesis by -22-unsaturated phytosterols via competitive inhibition of sterol -24-reductase in mammalian cells. Biochem. J. 366, 109-119
21. Zerenturk, E. J., Kristiana, I., Gill, S. and Brown, A. J. (2011) The endogenous regulator 24(S),25-epoxycholesterol inhibits cholesterol synthesis at DHCR24 (Seladin-1). Biochim. Biophys. Acta 1821, 1269-1277
22. Horton, J. D., Shah, N. A., Warrington, J. A., Anderson, N. N., Park, S. W., Brown, M. S. and Goldstein, J. L. (2003) Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. U.S.A. 100, 12027-12032
23. Reed, B. D., Charos, A. E., Szekely, A. M., Weissman, S. M. and Snyder, M. (2008) Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes. PLoS Genet. 4, e1000133
24. Zerenturk, E. J., Sharpe, L. J. and Brown, A. J. (2012) Sterols regulate 3?-hydroxysterol -24-reductase (DHCR24) via dual sterol regulatory elements: cooperative induction of key enzymes in lipid synthesis by sterol regulatory element binding proteins. Biochim. Biophys. Acta 1821, 1350-1360
25. Luciani, P., Deledda, C., Rosati, F., Benvenuti, S., Cellai, I., Dichiara, F., Morello, M., Vannelli, G. B., Danza, G., Serio, M. and Peri, A. (2008) Seladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures. Endocrinology 149, 4256-4266
26. Yoshinari, K., Ohno, H., Benoki, S. and Yamazoe, Y. (2011) Constitutive androstane receptor transactivates the hepatic expression of mouse Dhcr24 and human DHCR24 encoding a cholesterogenic enzyme 24-dehydrocholesterol reductase. Toxicol. Lett. 208, 185-191
27. Wang, Y., Rogers, P. M., Stayrook, K. R., Su, C., Varga, G., Shen, Q., Nagpal, S. and Burris, T. P. (2008) The selective Alzheimer's disease indicator-1 gene (Seladin-1/DHCR24) is a liver X receptor target gene. Mol. Pharmacol. 74, 1716-1721
28. Drzewinska, J., Walczak-Drzewiecka, A. and Ratajewski, M. (2010) Identification and analysis of the promoter region of the human DHCR24 gene: involvement of DNA methylation and histone acetylation. Mol. Biol. Rep. 38, 1091-1101
29. Rodriguez-Acebes, S., Cueva, P. D., Ferruelo, A. J., Fernandez-Hernando, C., Lasuncion, M. A., Martinez-Botas, J. and Gomez-Coronado, D. (2008) Dose-dependent dual effects of cholesterol and desmosterol on J774 macrophage proliferation. Biochem. Biophys. Res. Commun. 377, 484-488
30. Nelson, J. D., Denisenko, O. and Bomsztyk, K. (2006) Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 1, 179-185
31. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45
32. Schug, J. (2008) Using TESS to predict transcription factor binding sites in DNA sequence. Curr. Protoc. Bioinformatics Chapter 2, Unit 2.6
33. Swinnen, J. V., Ulrix, W., Heyns, W. and Verhoeven, G. (1997) Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc. Natl. Acad. Sci. U.S.A. 94, 12975-12980
34. Heemers, H., Maes, B., Foufelle, F., Heyns, W., Verhoeven, G. and Swinnen, J. V. (2001) Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol. Endocrinol. 15, 1817-1828
35. Lee, M. Y., Moon, J. S., Park, S. W., Koh, Y. K., Ahn, Y. H. and Kim, K. S. (2009) KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells. Biochem. J. 417, 313-322
36. Pearson, R., Fleetwood, J., Eaton, S., Crossley, M. and Bao, S. (2008) Kruppel-like transcription factors: a functional family. Int. J. Biochem. Cell Biol. 40, 1996-2001
37. Smale, S. T. and Kadonaga, J. T. (2003) The RNA polymerase II core promoter. Annu. Rev. Biochem. 72, 449-479
38. Edwards, P. A. and Ericsson, J. (1999) Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Annu. Rev. Biochem. 68, 157-185
39. Osborne, T. F. (2000) Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J. Biol. Chem. 275, 32379-32382
40. Usheva, A. and Shenk, T. (1996) YY1 transcriptional initiator: protein interactions and association with a DNA site containing unpaired strands. Proc. Natl. Acad. Sci. U.S.A. 93, 13571-13576
41. Nelson, P. S., Clegg, N., Arnold, H., Ferguson, C., Bonham, M., White, J., Hood, L. and Lin, B. (2002) The program of androgen-responsive genes in neoplastic prostate epithelium. Proc. Natl. Acad. Sci. U.S.A. 99, 11890-11895
42. Nuti, F., Luciani, P., Marinari, E., Erdei, E., Bak, M., Deledda, C., Rosati, F., Mazzinghi, B., Danza, G., Stoop, H. et al. (2009) Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness. J. Pathol. 219, 491-500
43. Dong, J. T. and Chen, C. (2009) Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol. Life. Sci. 66, 2691-2706
44. Nagarajan, R., Svaren, J., Le, N., Araki, T., Watson, M. and Milbrandt, J. (2001) EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 30, 355-368
45. Nagarajan, R., Le, N., Mahoney, H., Araki, T. and Milbrandt, J. (2002) Deciphering peripheral nerve myelination by using Schwann cell expression profiling. Proc. Natl. Acad. Sci. U.S.A. 99, 8998-9003
46. Leblanc, S. E., Srinivasan, R., Ferri, C., Mager, G. M., Gillian-Daniel, A. L., Wrabetz, L. and Svaren, J. (2005) Regulation of cholesterol/lipid biosynthetic genes by EGR2/Krox20 during peripheral nerve myelination. J. Neurochem. 93, 737-748
47. Matsushima-Nishiu, M., Unoki, M., Ono, K., Tsunoda, T., Minaguchi, T., Kuramoto, H., Nishida, M., Satoh, T., Tanaka, T. and Nakamura, Y. (2001) Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN. Cancer Res. 61, 3741-3749
48. Laslo, P., Spooner, C. J., Warmflash, A., Lancki, D. W., Lee, H. J., Sciammas, R., Gantner, B. N., Dinner, A. R. and Singh, H. (2006) Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 126, 755-766
49. Gabet, Y., Baniwal, S. K., Leclerc, N., Shi, Y., Kohn-Gabet, A. E., Cogan, J., Dixon, A., Bachar, M., Guo, L., Turman, Jr, J. E. and Frenkel, B. (2011) Krox20/EGR2 deficiency accelerates cell growth and differentiation in the monocytic lineage and decreases bone mass. Blood 116, 3964-3971
50. Fumagalli, R. and Paoletti, R. (1963) The identification and significance of desmosterol in the developing human and animal brain. Life Sci. 5, 291-295